ID20809A - Asam diaminokarboksilat tersubstitusi - Google Patents
Asam diaminokarboksilat tersubstitusiInfo
- Publication number
- ID20809A ID20809A IDP980666A ID980666A ID20809A ID 20809 A ID20809 A ID 20809A ID P980666 A IDP980666 A ID P980666A ID 980666 A ID980666 A ID 980666A ID 20809 A ID20809 A ID 20809A
- Authority
- ID
- Indonesia
- Prior art keywords
- diaminocarboxicate
- substituted
- acid
- substituted diaminocarboxicate
- diaminocarboxicate acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19719585A DE19719585A1 (de) | 1997-05-09 | 1997-05-09 | Substituierte Diaminocarbonsäuren |
DE19719428A DE19719428A1 (de) | 1997-05-12 | 1997-05-12 | Substituierte Diaminocarbonsäuren |
Publications (1)
Publication Number | Publication Date |
---|---|
ID20809A true ID20809A (id) | 1999-03-11 |
Family
ID=26036417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDP980666A ID20809A (id) | 1997-05-09 | 1998-05-07 | Asam diaminokarboksilat tersubstitusi |
Country Status (18)
Country | Link |
---|---|
US (2) | US6159995A (da) |
EP (1) | EP0877019B1 (da) |
JP (1) | JP4177484B2 (da) |
KR (1) | KR19980086893A (da) |
AR (1) | AR012675A1 (da) |
AT (1) | ATE210639T1 (da) |
AU (1) | AU736700B2 (da) |
BR (1) | BR9801604A (da) |
CA (1) | CA2237052A1 (da) |
CZ (1) | CZ143998A3 (da) |
DE (1) | DE59802394D1 (da) |
DK (1) | DK0877019T3 (da) |
ES (1) | ES2165640T3 (da) |
HU (1) | HUP9801045A3 (da) |
ID (1) | ID20809A (da) |
PL (1) | PL326218A1 (da) |
PT (1) | PT877019E (da) |
TR (1) | TR199800818A3 (da) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19719621A1 (de) * | 1997-05-09 | 1998-11-12 | Hoechst Ag | Sulfonylaminocarbonsäuren |
US6410580B1 (en) | 1998-02-04 | 2002-06-25 | Novartis Ag | Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
IL137465A0 (en) * | 1998-02-04 | 2001-07-24 | Novartis Ag | Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
CA2327290A1 (en) | 1998-04-03 | 1999-10-14 | Sankyo Company Limited | Sulfonamide derivatives |
PL199234B1 (pl) | 1998-07-16 | 2008-08-29 | Sanofi Aventis Deutschland | Pochodne kwasu fosfinowego i kwasu fosfonowego, związki pośrednie, sposób wytwarzania tych pochodnych, środek leczniczy, zastosowanie tych pochodnych i sposób wytwarzania środka leczniczego |
EP1165501A1 (en) * | 1999-03-03 | 2002-01-02 | The Procter & Gamble Company | Alkenyl- and alkynyl-containing metalloprotease inhibitors |
US6566381B1 (en) | 1999-03-03 | 2003-05-20 | The Procter & Gamble Company | Hetero-substituted metalloprotease inhibitors |
GB9918684D0 (en) | 1999-08-09 | 1999-10-13 | Novartis Ag | Organic compounds |
GB0103303D0 (en) | 2001-02-09 | 2001-03-28 | Novartis Ag | Organic compounds |
US6506786B2 (en) * | 2001-02-13 | 2003-01-14 | Pharmacor Inc. | HIV protease inhibitors based on amino acid derivatives |
ES2345977T3 (es) * | 2001-03-14 | 2010-10-07 | Novartis Ag | Derivados de acido acetico azacicloalquil sustituidos para uso como inhibidores de mmp. |
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
GB0412553D0 (en) * | 2004-06-04 | 2004-07-07 | Univ Aberdeen | Therapeutic agents for the treatment of bone conditions |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
US7388008B2 (en) * | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
US7576222B2 (en) | 2004-12-28 | 2009-08-18 | Wyeth | Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase |
WO2006114001A1 (en) * | 2005-04-27 | 2006-11-02 | Ambrilia Biopharma Inc. | Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors |
EP1971615B1 (en) * | 2005-11-30 | 2014-01-01 | TaiMed Biologics, Inc. | Lysme-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
JP5401652B2 (ja) * | 2006-09-21 | 2014-01-29 | タイメッド バイオロジクス インコーポレイテッド | プロテアーゼ阻害剤 |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
US8093265B2 (en) | 2007-03-09 | 2012-01-10 | Renovis, Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
GB0705400D0 (en) | 2007-03-21 | 2007-05-02 | Univ Aberdeen | Therapeutic compounds andm their use |
GB0817207D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | therapeutic apsac compounds and their use |
GB0817208D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | Therapeutic apsap compounds and their use |
GB201311361D0 (en) | 2013-06-26 | 2013-08-14 | Pimco 2664 Ltd | Compounds and their therapeutic use |
LT3262028T (lt) | 2014-12-17 | 2022-01-10 | Pimco 2664 Limited | N-(4-hidroksi-4-metil-cikloheksil)-4-fenil-benzensulfonamido ir n-(-4-hidroksi-4-metil-cikloheksil)-4-(2-piridil)-benzensulfonamido junginiai ir jų terapinis panaudojimas |
EP3560917B1 (en) * | 2016-12-22 | 2023-12-20 | Guangzhou Chinaray Optoelectronic Materials Ltd. | Polymer containing furan crosslinking group and use thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2764262B2 (ja) * | 1987-08-28 | 1998-06-11 | 持田製薬株式会社 | ヒダントイン誘導体及びそれを有効成分とする医薬組成物 |
TW201303B (da) * | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5506242A (en) * | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
GB2303850B (en) * | 1994-06-22 | 1998-06-10 | British Biotech Pharm | Metalloproteinase inhibitors |
US5863949A (en) * | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
US5861510A (en) * | 1995-04-20 | 1999-01-19 | Pfizer Inc | Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors |
KR980009238A (ko) * | 1995-07-28 | 1998-04-30 | 우에노 도시오 | 설포닐아미노산 유도체 |
AU727569B2 (en) * | 1995-11-17 | 2000-12-14 | Warner-Lambert Company | Sulfonamide inhibitors of matrix metalloproteinases |
EP0915086A4 (en) | 1996-05-24 | 2001-01-17 | Ono Pharmaceutical Co | PHENYLSULFONAMIDE DERIVATIVES |
-
1998
- 1998-05-02 DE DE59802394T patent/DE59802394D1/de not_active Expired - Lifetime
- 1998-05-02 AT AT98108040T patent/ATE210639T1/de not_active IP Right Cessation
- 1998-05-02 DK DK98108040T patent/DK0877019T3/da active
- 1998-05-02 ES ES98108040T patent/ES2165640T3/es not_active Expired - Lifetime
- 1998-05-02 EP EP98108040A patent/EP0877019B1/de not_active Expired - Lifetime
- 1998-05-02 PT PT98108040T patent/PT877019E/pt unknown
- 1998-05-07 CZ CZ981439A patent/CZ143998A3/cs unknown
- 1998-05-07 AR ARP980102140A patent/AR012675A1/es unknown
- 1998-05-07 TR TR1998/00818A patent/TR199800818A3/tr unknown
- 1998-05-07 CA CA002237052A patent/CA2237052A1/en not_active Abandoned
- 1998-05-07 ID IDP980666A patent/ID20809A/id unknown
- 1998-05-08 HU HU9801045A patent/HUP9801045A3/hu unknown
- 1998-05-08 PL PL98326218A patent/PL326218A1/xx unknown
- 1998-05-08 AU AU64824/98A patent/AU736700B2/en not_active Ceased
- 1998-05-08 BR BR9801604A patent/BR9801604A/pt not_active IP Right Cessation
- 1998-05-08 US US09/074,587 patent/US6159995A/en not_active Expired - Lifetime
- 1998-05-08 JP JP16270798A patent/JP4177484B2/ja not_active Expired - Fee Related
- 1998-05-09 KR KR1019980016598A patent/KR19980086893A/ko not_active Application Discontinuation
-
2000
- 2000-10-18 US US09/690,475 patent/US6355673B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
TR199800818A2 (xx) | 1998-11-23 |
ATE210639T1 (de) | 2001-12-15 |
US6355673B1 (en) | 2002-03-12 |
US6159995A (en) | 2000-12-12 |
CA2237052A1 (en) | 1998-11-09 |
EP0877019A1 (de) | 1998-11-11 |
PT877019E (pt) | 2002-05-31 |
HUP9801045A2 (hu) | 1999-06-28 |
DE59802394D1 (de) | 2002-01-24 |
AR012675A1 (es) | 2000-11-08 |
BR9801604A (pt) | 1999-06-08 |
JPH11228529A (ja) | 1999-08-24 |
HU9801045D0 (en) | 1998-07-28 |
CZ143998A3 (cs) | 1998-11-11 |
TR199800818A3 (tr) | 1998-11-23 |
DK0877019T3 (da) | 2002-04-08 |
ES2165640T3 (es) | 2002-03-16 |
KR19980086893A (ko) | 1998-12-05 |
JP4177484B2 (ja) | 2008-11-05 |
AU6482498A (en) | 1998-11-12 |
AU736700B2 (en) | 2001-08-02 |
PL326218A1 (en) | 1998-11-23 |
EP0877019B1 (de) | 2001-12-12 |
HUP9801045A3 (en) | 2000-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID20809A (id) | Asam diaminokarboksilat tersubstitusi | |
ID20807A (id) | Asam sulfonilaminokarboksilat | |
ID26222A (id) | Hidroksamida asam(4-arilsulfonilamino)-tetrahidropiran-4-karboksilat | |
ID28833A (id) | Turunan asam 3-aril-2-hidroksipropionat | |
ID23668A (id) | Turunan asam ariloksiarilsulfonilamino hidroksamat | |
ID22799A (id) | Turunan-turunan asam arilsulfonilamino hidroksamat | |
ID22809A (id) | Turunan-turunan asam arilsulfonil hidroksamat | |
ID28699A (id) | Turunan-turunan asam oksiiminoalkanoat | |
ID22095A (id) | Asam aril-akrilat ester | |
ID18063A (id) | Turunan-turunan asam arilsufonilamino hidroksamat | |
ID24376A (id) | Turunan-turunan asam amidokarboksilat | |
ID24626A (id) | Turunan-turunan asam hidroksamat sebagai penghambat metaloprotease matriks (mmp) | |
ATE269861T1 (de) | Substituierte indolalkansäure | |
ID26978A (id) | Turunan-turunan asam aminometilkarboksilat | |
ID23502A (id) | Pembuatan asam tereftalat | |
ID24686A (id) | Enzim-enzim biosintetik asam amino tanaman | |
TR199802106A3 (tr) | Sübstitüe edilmis izokinolin-3-karbon asidi amidleri. | |
ATE250583T1 (de) | Substituierte 3-cyanochinoline | |
ID28164A (id) | Turunan iii asam 3-aril-2-hidroksipropionat baru | |
ID27390A (id) | Pembuatan asam akrilat | |
TR199802289A3 (tr) | Fosfonasit-ikame etmis benzazepinon-n-asetikasit türevleri. | |
DE69606053T2 (de) | Modifizierte fluorsulfonsäure | |
DE59813487D1 (de) | Substituierte 4-benzoyl-pyrazole | |
ID17416A (id) | Pembuatan asam akrilat | |
ID28810A (id) | Senyawa-senyawa amida-omega asam n-arilsulfonilamino |